UNT System College of Pharmacy

Projects

Projects per year 1991 2013 2014 2015 2017 2018 2019 2020 2021 2022 2031

• 1 Not started
• 22 Active
• 213 Finished

Projects per year

Search results

• Finished

  Revagenix SOW#7: Efficacy of S

  Weiss, W. (PI)

  Revagenix, Inc.

  22/01/24 → 31/08/24

  Project: Research

• RG6006 (Zosurabalpin) Pharmaco

  Weiss, W. (PI)

  F. Hoffman-La Roche Ltd.

  1/01/24 → 31/12/24

  Project: Research

• Discovery of synthetic flavonoids for the treatment of corneal injury

  Karamichos, D. (PI) & Emmitte, K. (CoPI)

  National Eye Institute

  1/01/24 → 31/12/24

  Project: Research

  • Corneal Injury 100%
  • Synthetic Flavonoid 100%
  • Flavonoid 100%
  • Cornea Injury 100%
  • Corneal Fibrosis 80%

• Revagenix 2023-24

  Weiss, W. (PI)

  Revagenix, Inc.

  1/09/23 → 31/08/24

  Project: Research

• Mechanistic Insights and Thera

  Wu, H. (PI)

  NEI: National Eye Institute

  1/02/23 → 31/01/25

  Project: Research

• Clarametyx 2022-008: Immunogenicity screening of three high-dose peptide immunogen concentrations with Alhydrogel®, administered subcutaneously naïve wild type mice

  Weiss, W. (PI)

  Clarametyx Biosciences, Inc.

  21/07/22 → 20/07/23

  Project: Research

• Placental Autophagy in a Precl

  Cunningham, R. (PI)

  American Heart Association

  1/07/22 → 30/06/24

  Project: Research

• Maternal vascular responses to extracellular mitochondrial DNA during pregnancy

  Cunningham, R. (PI)

  Loma Linda University

  1/07/22 → 30/06/23

  Project: Research

• Clarametyx 2022-06: Immunogenicity screening of three high-dose peptide immunogen concentrations without an adjuvant, administered subcutaneously naïve wild type mice

  Weiss, W. (PI)

  Clarametyx Biosciences, Inc.

  6/06/22 → 5/06/23

  Project: Research

• Efficacy and Pharmacokinetics in the murine neutropenic thigh infection and murine neutropenic lung infection models with P. aeruginosa

  Weiss, W. (PI)

  Genentech

  1/06/22 → 15/06/23

  Project: Research

• Clarametyx 2022-05: Immunogenicity assessment of a peptide immunogen in naive mice - adjuvant screening

  Weiss, W. (PI)

  Clarametyx Biosciences, Inc.

  21/02/22 → 20/02/23

  Project: Research

• Clarametyx 2022-04: Establishment of a rat experimental acute otitis media model in rats

  Weiss, W. (PI)

  Clarametyx Biosciences, Inc.

  14/02/22 → 13/02/23

  Project: Research

• Study Genentech 2021-03: Efficacy and Pharmacokinetics in the murine neutropenic thigh infection and murine neutropenic lung infection models with Acinetobacter baumannii

  Weiss, W. (PI)

  Genentech

  8/02/22 → 7/02/23

  Project: Research

• Building Better Antioxidants: Virtual Screening, Synthesis, and Characterization of Multifunctional Small Molecules Combining Nrf2 Pathway Activation and Direct Antioxidant Activity

  Wu, H. (PI)

  TEXAS CHRISTIAN UNIVERSITY

  1/02/22 → 31/01/25

  Project: Research

• Clarametyx 2022-01: Immunogenicity assessment of a peptide immunogen in naïve mice ¿ adjuvant screening

  Weiss, W. (PI)

  Clarametyx Biosciences, Inc.

  6/01/22 → 5/01/23

  Project: Research

• Small Molecule Slack Channel Inhibitors for the Treatment of Epilepsies

  Emmitte, K. (PI)

  VANDERBILT UNIVERSITY

  1/01/22 → 30/09/23

  Project: Research

• New Approach for Neuroprotection of Photoreceptors by Targeting TMEM97/sigma2R

  Kastellorizios, M. (PI)

  University of Texas - Austin

  1/01/22 → 30/11/23

  Project: Research

• Texas CEAL Consortium

  Spence, E. (PI), Wagner, T. (CoI) & Sambamoorthi, U. (CoI)

  Westat, Inc.

  1/11/21 → 31/08/23

  Project: Research

• Curza 2021-01: Efficacy of novel therapeutic agents in the murine UTI model

  Weiss, W. (PI)

  CURZA Global LLC

  18/10/21 → 30/04/22

  Project: Research

• Role of Estrogen Signaling in

  Bunnell, B. (PI) & Cunningham, R. (CoI)

  Lipedema Foundation

  1/10/21 → 31/07/24

  Project: Research

• Clarametyx 2021-07: Pharmacokinetics of submitted test article in naive and P. aeruginosa lung infected mice

  Weiss, W. (PI)

  Clarametyx Biosciences, Inc.

  28/09/21 → 9/07/22

  Project: Research

• Low-Value Services Use Among O

  Zhou, B. (PI) & Neba, R. (CoI)

  Office of the Director, NIH

  17/09/21 → 16/03/25

  Project: Research

• AIM-AHEAD Coordinating Center

  Vishwanatha, J. (PI), Jones, H. (CoI), Basha, R. (CoI), Sambamoorthi, U. (CoI) & Zhou, B. (CoI)

  Office of the Director, NIH

  17/09/21 → 16/03/25

  Project: Research

• AIM-AHEAD Coordinating Center - All Four Cores

  Jones, H. (CoPI), CASILLAS, A. (CoPI), Carlisle, A. (CoPI), Shanker, A. (CoPI), Beech, B. (CoPI), Malin, B. (CoPI), Borrayo, E. (CoPI), Taylor, H. (CoPI), Puro, J. (CoPI), Norris, K. (CoPI), Burge, L. (CoPI), JUAREZ, P. (CoPI), Avillach, P. (CoPI), THORPE, R. (CoPI), MANSON, S. (CoPI), Abdul-Ali, A. (CoPI), Syed, T. (CoPI), Jones, H. (CoPI), Vishwanatha, J. (PI) & Sambamoorthi, U. (CoPI)

  NIH Office of the Director

  17/09/21 → 16/03/24

  Project: Research

• INACTIVE

  Neba, R. (CoI) & Vishwanatha, J. (PI)

  Office of the Director, NIH

  17/09/21 → 16/03/25

  Project: Research

• Clarametyx 2021-05: Dose Ranging Efficacy Study in the Murine Lung Infection Model with Pseudomonas Aeruginosa

  Weiss, W. (PI)

  Clarametyx Biosciences, Inc.

  11/08/21 → 9/07/22

  Project: Research

• Genentech 2021-02: Pharmacokinetics and Dose Response/Fractionation of GDC-5780 in the murine lung infection model with select enterobacteriaceae isolates

  Weiss, W. (PI)

  Genentech

  13/07/21 → 12/07/22

  Project: Research

• Taxis 2021-05: Study Taxis 2021-05: Efficacy Study of YZZ-9-155 in combination with ceftazidime in murine lung infection model

  Weiss, W. (PI)

  TAXIS Pharmaceuticals, Inc.

  13/05/21 → 31/12/21

  Project: Research

• Bioversys 2021-04: Efficacy and Pharmacokinetics of novel test articles in a murine lung infection model withKlebsiella pneumoniae

  Weiss, W. (PI)

  BioVersys AG

  1/05/21 → 28/11/22

  Project: Research

• Taxis 2021-04: Efficacy of YY-10-68 with Levofloxacin in the Murine Lung Infection Model with P. aeruginosa

  Weiss, W. (PI)

  TAXIS Pharmaceuticals, Inc.

  17/03/21 → 16/03/22

  Project: Research

• Taxis 2021-03: Determination of safety, tolerability and efficacy of submitted novel test articles

  Weiss, W. (PI)

  TAXIS Pharmaceuticals, Inc.

  3/03/21 → 2/03/22

  Project: Research

• Bioversys 2021-01: Murine dermonecrosis model with S. aureus and efficacy of antivirulence compounds

  Weiss, W. (PI)

  BioVersys AG

  3/02/21 → 14/03/22

  Project: Research

• Taxis 2021-01: Efficacy of a Novel Efflux Pump Inhibitors with Levofloxacin in the Murine Lung and Thigh Infection Models with P. aeruginosa

  Weiss, W. (PI)

  TAXIS Pharmaceuticals, Inc.

  27/01/21 → 26/01/22

  Project: Research

• Amicrobe 2021-01: Development of an S. aureus Intrauterine Infection Model in Mice

  Weiss, W. (PI)

  Amicrobe, Inc.

  22/01/21 → 21/01/22

  Project: Research

• Amicrobe 2021-03: system for the evaluation of Amicidin activity on bacterial colonization of VITRO-SKIN

  Weiss, W. (PI)

  Amicrobe, Inc.

  22/01/21 → 21/01/22

  Project: Research

• Genentech 2020-02: Dose Fractionation of Genetech Test Genentech 2020-02: Dose Fractionation of Genetech Test Article in the murine thigh infection model with select enterobacteriaceae isolates

  Weiss, W. (PI)

  Genentech

  12/01/21 → 11/01/22

  Project: Research

• Clarametyx 2021-02: Efficacy of CMTX-101 in the Murine Lung infection Model with Streptococcus pneumoniae

  Weiss, W. (PI)

  Clarametyx Biosciences, Inc.

  11/01/21 → 10/01/22

  Project: Research

• Clarametyx 2021-01: Efficacy of a Novel Antibody in the Rat Endocarditis Infection Model with Staphylococcus aureus

  Weiss, W. (PI)

  Clarametyx Biosciences, Inc.

  4/01/21 → 3/01/22

  Project: Research

• Biodistribution Studies of Bacteriophage

  Weiss, W. (PI)

  Janssen Pharmaceuticals

  18/12/20 → 17/06/22

  Project: Research

• Discovery of small molecule activators of the Slack potassium channel for use as cell-based probes for the study of fragile X syndrome

  WEAVER, D. (CoPI), WEAVER, C. (CoPI), EMMITTE, K. (PI), Emmitte, K. (CoPI) & Emmitte, K. (PI)

  1/12/20 → 31/10/22

  Project: Research

  • Cell-based 100%
  • Fragile X Syndrome 100%
  • Potassium Channel 100%
  • Small Molecule Activation 100%
  • Genetic Disorder 100%

• Discovery of small molecule activators of the Slack potassium channel for use as cell-based probes for the study of fragile X syndrome

  Emmitte, K. (PI) & WEAVER, D. (CoPI)

  National Institute of Mental Health

  1/12/20 → 31/10/21

  Project: Research

  • Cell-based 100%
  • Small Molecule Activation 100%
  • Fragile X Syndrome 100%
  • Potassium Channel 100%
  • Ion Channel 100%

• Discovery of Small Molecule Activators of the Slack Potassium Channel for Use as Cell-Based Probes for the Study of Fragile X Syndrome

  Emmitte, K. (PI)

  NIMH: Mental Health

  1/12/20 → 31/10/23

  Project: Research

• Study Versatope 2020-01: Prophylactic potential of test articles in the hamster infection model of C. difficile disease (HCDAD)

  Weiss, W. (PI)

  Versatope Therapeutics, Inc.

  18/11/20 → 17/11/21

  Project: Research

• FCCDC 2020-03: Model Development and Test Article Efficacy in a Murine Disseminated Infection Model with Fusarium and Aspergillus isolates

  Weiss, W. (PI)

  Fox Chase Chemical Diversity Center, Inc

  11/11/20 → 10/05/22

  Project: Research

• Efficacy of the Novel Ciprofloxacin conjugate RLA-4784 in the murine lung model with P. aeruginosa

  Weiss, W. (PI)

  UNIVERSITY OF CALIFORNIA SAN FRANCISCO

  2/10/20 → 1/10/21

  Project: Research

• Clarametyx 2020-06: Efficacy of Novel Antibody(s) in the Rodent Models of Bacterial Infection

  Weiss, W. (PI)

  Clarametyx Biosciences, Inc.

  21/09/20 → 20/09/21

  Project: Research

• Genentech 2020-01: Pharmacokinetics and efficacy of Genentech Test Article in the murine thigh infection model with E. coli and K. pneumoniae

  Weiss, W. (PI)

  Genentech

  18/09/20 → 7/06/21

  Project: Research

• Texas CEAL Consortium

  Spence, E. (PI), Wagner, T. (CoI) & Sambamoorthi, U. (CoI)

  RTI International

  9/09/20 → 31/10/21

  Project: Research

• Evaluation of Response to Human Antithrombin-III (Thrombate®) in Pediatric Patients Supported by Extracorporeal Membrane Oxygenation

  Chaturvedula, A. (PI)

  JOHNS HOPKINS UNIVERSITY

  1/09/20 → 31/08/21

  Project: Research

• Entasis 2020-01: Efficacy of Novel Therapeutic Combinations in the Murine UTI Model with Four E. Coli Isolates

  Weiss, W. (PI)

  Entasis Therapeutics

  1/08/20 → 31/07/21

  Project: Research